Stock 1177 SINO BIOPHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Delayed Hong Kong S.E.
Other stock markets
 01:51:00 2024-05-30 am EDT 		5-day change 1st Jan Change
2.81 HKD +0.36% Intraday chart for Sino Biopharmaceutical Limited -4.44% -19.31%
May. 24 Sino Biopharmaceutical's Renal Cancer Combination Treatment Shows Promise in Phase III Trials MT
May. 23 Sino Biopharmaceutical Limited Announces Positive Results on Phase III Study of Benmelstobart Injection in Combination with Anlotinib Hydrochloride Capsules for First-Line Treatment of Advanced Renal Cell Carcinoma CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1177 Stock
  4. News Sino Biopharmaceutical Limited
  5. MarketScreener Strategies